Prevention of β Thalassemia in Northern Israel - a Cost-Benefit Analysis

BACKGROUND: β Thalassemia major is characterized by hemolytic anemia, ineffective erythropoiesis and hemosiderosis. About 4% of the world population carries a Thalassemia gene. Management includes blood transfusions and iron chelation. However, this treatment is costly, and population screening may...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Koren, Ariel, Profeta, Lora, Zalman, Luci, Palmor, Haya, Levin, Carina, Zamir, Ronit Bril, Shalev, Stavit, Blondheim, Orna
Médium: Artigo
Jazyk:Inglês
Vydáno: Università Cattolica del Sacro Cuore 2014
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3965716/
https://ncbi.nlm.nih.gov/pubmed/24678389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2014.012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky